| Glenmark Generics Ltd. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120028045 | Processes for the Preparation of Indiplon and Intermediates Thereof - The present invention relates to processes for the preparation of indiplon and its polymorphic mixtures. | 02-02-2012 |
| 20120022047 | PROCESS FOR THE PURIFICATION OF ESLICARBAZEPINE ACETATE - The present invention relates to the purification and particle size of eslicarbazepine acetate. The present invention also relates to the physical characteristics of solid state eslicarbazepine acetate, and pharmaceutical compositions containing the same. | 01-26-2012 |
| 20110281928 | Process for the preparation of zofenopril and its pharmaceutically acceptable salts thereof - The present invention relates to a process for the preparation of zofenopril and its pharmaceutically acceptable salts and a pharmaceutical composition thereof. The present invention also provides structurally novel compounds, which are useful intermediates in the synthesis of zofenopril. | 11-17-2011 |
| 20110207779 | PROCESS FOR THE PREPARATION OF ESOMEPRAZOLE MAGNESIUM - The present invention relates to a process for the preparation of esomeprazole magnesium containing R-isomer greater than about 0.1% by wt. In particular, the present invention relates to a process for the preparation of esomeprazole magnesium dihydrate containing R-isomer greater than about 0.1% by wt. | 08-25-2011 |
| 20110105619 | AMORPHOUS BUPROPION HYDROBROMIDE AND PREPARATION THEREOF - The present invention provides an amorphous bupropion hydrobromide and an amorphous bupropion hydrobromide granulates with at least one pharmaceutically acceptable carrier, and a process for its preparation. | 05-05-2011 |
| 20110053898 | TOPICAL COMPOSITION COMPRISING VITAMIN D ANALOGUE AND CORTICOSTEROIDS - A topical pharmaceutical composition comprising therapeutically effective amounts of vitamin D or vitamin D analogues, corticosteroid and a straight chain C | 03-03-2011 |
| 20110052687 | EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF PALIPERIDONE - The present invention provides an extended release tablet of paliperidone, comprising a) a core containing paliperidone and at least one water soluble and/or gellable polymer, b) a coating comprising at least one water insoluble or permeable polymer, and a water soluble and/or gellable polymer and optionally an enteric polymer. | 03-03-2011 |
| 20110038928 | ORALLY DISINTEGRATING TABLETS OF ZOLMITRIPTAN - The present invention is directed to a novel rapidly dissolvable pharmaceutical composition comprising zolmitriptan or pharmaceutically acceptable salts or esters thereof and least one direct compression filler. The pharmaceutical compositions of the present invention can advantageously be prepared in a solid dosage form, e.g. a tablet, utilizing directly compressible ingredients. | 02-17-2011 |
| 20100317856 | PROCESS FOR THE PREPARATION OF R-SITAGLIPTIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF - The present invention provides processes for the preparation of R-sitagliptin and its pharmaceutically acceptable salts thereof. | 12-16-2010 |
| 20100310870 | AMORPHOUS BAZEDOXIFENE ACETATE AND PREPARATION THEREOF - The present invention relates to amorphous form of bazedoxifene acetate and a process for the preparation thereof. | 12-09-2010 |
| 20100292267 | PALONOSETRON FREE BASE AND PROCESS FOR ITS PREPARATION - The present invention provides novel palonosetron free base in an amorphous form and crystalline form-G and processes for their preparation. The present invention also provides a process for the preparation of palonosetron hydrochloride from the novel palonosetron free base in an amorphous form and/or in crystalline form-G. | 11-18-2010 |
| 20100068284 | Stable Fixed Dose Topical Formulation - The present invention relates to stable fixed dose topical formulations comprising an antiacne agent and an antibiotic, which exhibit storage stability at a temperature of about 40° C. and relative humidity of about 75% for a period of at least 3 months. Particularly, the present invention relates to stable fixed dose topical formulations comprising therapeutically effective amounts of (a) adapalene-containing microspheres and (b) clindamycin, a process for their preparation thereof and their use for the treatment of acne. | 03-18-2010 |
| 20100028425 | PHARMACEUTICAL COMPOSITION OF ATOVAQUONE - The present invention relates to immediate release pharmaceutical compositions for oral administration comprising micronized atovaquone particles and at least one drug, wherein about 90% of the atovaquone particles have a volume diameter between about 4 μm to about 8 μm; and having a uniform release profile after a storage for at least three months at 40° C. and 75% relative humidity. | 02-04-2010 |
| 20100008988 | TABLET COMPOSITIONS OF AMINE POLYMERS - The present invention provides pharmaceutical compositions, essentially comprising less than about 95% by weight of an aliphatic amine polymer. The present invention relates to pharmaceutical compositions comprising aliphatic amine polymers of sevelamer hydrochloride, sevelamer carbonate and colesevelam hydrochloride; and methods of preparing pharmaceutical compositions thereof. | 01-14-2010 |
| 20100008986 | PHARMACEUTICAL COMPOSITIONS COMPRISING SUMATRIPTAN AND NAPROXEN - The present invention relates to the pharmaceutical composition comprising sumatriptan succinate and naproxen sodium, with a proviso that both the active components are in admixture with each other. | 01-14-2010 |
| 20100004338 | TOPICAL GEL COMPOSITION COMPRISING AZELAIC ACID - The present invention discloses a novel azelaic acid topical pharmaceutical gel composition that does not contain lecithin and a process for its preparation. | 01-07-2010 |
| 20100003319 | RALOXIFENE IMMEDIATE RELEASE TABLETS - The present invention relates generally to formulations containing raloxifene or pharmaceutical salts thereof, as the active pharmaceutical ingredient and a process for preparing the same. | 01-07-2010 |
| 20090298884 | Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same - A strontium salt of esomeprazole is provided. A process for preparing a strontium salt of esomeprazole is also provided comprising reacting esomeprazole free base or a sodium, potassium or lithium salt of esomeprazole with a strontium source in one or more solvents. | 12-03-2009 |
| 20090298803 | PHARMACEUTICAL COMPOSITION COMPRISING FLUOCINONIDE - The present invention provides a composition, comprising fluocinonide in a vehicle comprising one or two penetration enhancers, solvents and emulsifiers wherein penetration enhancers are present in ratio of less than 0.90 to the total of the penetration enhancers, solvents and emulsifiers. | 12-03-2009 |
